Bill Anderson, Bayer CEO (Photo by: Henning Kaiser/picture-alliance/dpa/AP Images)
May 13, 2025 06:37 AM EDT
People
Pharma

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

Ayisha Sharma

News Reporter

Bay­er has been ramp­ing up lay­offs in re­cent months as it edges clos­er to its end-of-year tar­get to com­plete its man­age­ment re­or­ga­ni­za­tion that was first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

Up­dat­ed: To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Dutch biotech gets $146M for late-stage tri­als in three meta­bol­ic dis­or­ders

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

A service from the Financial Times